Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-05-10 Purchase |
2024-05-13 08:47 am |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
1,113 | $6.32 | $7,034 | 1,493,068 (Direct) |
View |
| 2023-03-21 Purchase |
2023-03-22 08:30 am |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
420 | $11.99 | $5,036 | 1,361,955 (Direct) |
View |
| 2023-03-15 Purchase |
2023-03-17 08:31 am |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
670 | $10.71 | $7,176 | 1,361,535 (Direct) |
View |
| 2022-12-21 Purchase |
2022-12-22 08:30 am |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
500 | $7.65 | $3,825 | 1,245,865 (Direct) |
View |
| 2022-11-16 Purchase |
2022-11-18 08:30 am |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
300 | $7.15 | $2,145 | 1,245,365 (Direct) |
View |
| 2022-09-23 Purchase |
2022-09-27 08:45 am |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
220 | $7.87 | $1,731 | 1,245,065 (Direct) |
View |
| 2022-09-02 Purchase |
2022-09-06 08:00 am |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
404 | $8.31 | $3,357 | 1,244,845 (Direct) |
View |
| 2022-08-31 Purchase |
2022-09-02 08:30 am |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
3,006 | $8.07 | $24,258 | 1,244,441 (Direct) |
View |
| 2022-05-20 Purchase |
2022-05-23 08:31 am |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
300 | $16.54 | $4,962 | 1,241,435 (Direct) |
View |
| 2022-05-16 Purchase |
2022-05-18 08:31 am |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
242 | $19.44 | $4,704 | 1,241,135 (Direct) |
View |
| 2022-05-12 Purchase |
2022-05-13 08:30 am |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
1,278 | $15.85 | $20,255 | 1,240,893 (Direct) |
View |
| 2022-02-04 Purchase |
2022-02-08 6:00 pm |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Development Officer |
2,946 | $3.4058 | $10,034 | 1,179,615 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-02 Option Award |
2025-01-03 6:13 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
150,000 | $0 | 1,643,068 (Direct) |
View |
| 2024-01-03 Option Award |
2024-01-05 4:30 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
130,000 | $0 | 1,491,955 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-13 5:04 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
115,000 | $0 | 1,360,865 (Direct) |
View |
| 2022-04-01 Option Award |
2022-04-05 4:46 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
60,000 | $0 | 1,239,615 (Direct) |
View |
Ownership |
2022-02-08 08:37 am |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Development Officer |
0 | $0 | 1,176,669 (Direct) |
View |